Investor’s Toolkit: Key Ratios for Assessing Wave Life Sciences Ltd. (WVE)’s Performance

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Wave Life Sciences Ltd. (NASDAQ: WVE) closed the day trading at $5.25 up 1.74% from the previous closing price of $5.16. In other words, the price has increased by $1.74 from its previous closing price. On the day, 1.37 million shares were traded. WVE stock price reached its highest trading level at $5.35 during the session, while it also had its lowest trading level at $5.14.

Ratios:

For a better understanding of WVE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.19. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.71.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on May 15, 2024, initiated with a Overweight rating and assigned the stock a target price of $11.

On December 19, 2023, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $5 to $12.

On July 05, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $7.Raymond James initiated its Outperform rating on July 05, 2023, with a $7 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 03 ’24 when Moran Kyle sold 15,630 shares for $6.17 per share. The transaction valued at 96,421 led to the insider holds 33,921 shares of the business.

RA CAPITAL MANAGEMENT, L.P. bought 1,000,000 shares of WVE for $5,000,000 on Dec 11 ’23. The Director now owns 19,202,009 shares after completing the transaction at $5.00 per share. On Dec 07 ’23, another insider, GSK plc, who serves as the 10% Owner of the company, bought 3,300,000 shares for $5.00 each. As a result, the insider paid 16,500,000 and bolstered with 13,983,761 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 642915008 and an Enterprise Value of 500401856. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.69 while its Price-to-Book (P/B) ratio in mrq is 25.29. Its current Enterprise Value per Revenue stands at 4.432 whereas that against EBITDA is -7.407.

Stock Price History:

Over the past 52 weeks, WVE has reached a high of $7.67, while it has fallen to a 52-week low of $3.45. The 50-Day Moving Average of the stock is -8.84%, while the 200-Day Moving Average is calculated to be -1.77%.

Shares Statistics:

Over the past 3-months, WVE traded about 579.25K shares per day on average, while over the past 10 days, WVE traded about 553190 shares per day. A total of 119.16M shares are outstanding, with a floating share count of 96.53M. Insiders hold about 21.17% of the company’s shares, while institutions hold 74.68% stake in the company. Shares short for WVE as of 1715731200 were 2772670 with a Short Ratio of 4.37, compared to 1713139200 on 3151130. Therefore, it implies a Short% of Shares Outstanding of 2772670 and a Short% of Float of 3.3000000000000003.

Most Popular